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Background: Bladder calculus is associated with chronic irritation and inflammation. As there is substantial
documentation that inflammation can play a direct role in carcinogenesis, to date the relationship between stone
formation and bladder cancer (BC) remains unclear. This study aimed to examine the association between BC and
prior bladder calculus using a population-based dataset.
Methods: This case–control study included 2,086 cases who had received their first-time diagnosis of BC between
2001 and 2009 and 10,430 randomly selected controls without BC. Conditional logistic regressions were employed
to explore the association between BC and having been previously diagnosed with bladder calculus.
Results: Of the sampled subjects, bladder calculus was found in 71 (3.4%) cases and 105 (1.1%) controls.
Conditional logistic regression analysis revealed that the odds ratio (OR) of having been diagnosed with bladder
calculus before the index date for cases was 3.42 (95% CI = 2.48-4.72) when compared with controls after adjusting
for monthly income, geographic region, hypertension, diabetes, coronary heart disease, and renal disease, tobacco
use disorder, obesity, alcohol abuse, and schistosomiasis, bladder outlet obstruction, and urinary tract infection. We
further analyzed according to sex and found that among males, the OR of having been previously diagnosed with
bladder calculus for cases was 3.45 (95% CI = 2.39-4.99) that of controls. Among females, the OR was 3.05 (95% CI =
1.53-6.08) that of controls.
Conclusions: These results add to the evidence surrounding the conflicting reports regarding the association
between BC and prior bladder calculus and highlight a potential target population for bladder cancer screening.
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Urinary calculi (UC) is a common genitourinary disorder
with a worldwide lifetime incidence of 10–15% [1]. With
the exception of the two World Wars, the incidence of
UC has been increasing among both adults and children
over the past 100 years [2-4]. Therefore, on account of
the relatively high and increasing incidence rate of UC,
it is important to understand what sequelae may affect
the many survivors of this low-mortality condition.
Bladder cancer (BC) is one of the most common hu-
man cancers [5]; in the United States it is fifth most
commonly diagnosed cancer [6], and the eighth most
common cause of death among men with cancer [7]. In* Correspondence: henry11111@tmu.edu.tw
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reproduction in any medium, provided the orthe United States alone, nearly 44,690 men and 16,730
women were diagnosed with bladder cancer in 2006 [8],
and the incidence has also been reported to be increas-
ing [9]. It has been proposed that the chronic irritation
and inflammation associated with UC may cause alte-
rations in the local environment and subsequently lead
to urothelial proliferation and the development of malig-
nant neoplasms, especially transitional cell carcinoma
(TCC) [10].
While the incidence of BC is high in most developing
countries, its chief etiology is different from that of de-
veloped countries. Most cases in developing countries
occur on account of infections with members of the
genus Schistosoma, with 75% of all BC cases being squa-
mous cell carcinomas [8,9]. This stands in contrast to
BC cases in developed countries such as the United
States, where TCC is reported to be the pathologyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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possible that the inflammation stemming from bladder
calculus may be associated with BC. Although urinary
tract infections have previously been considered to be a
risk factor [13-15], to date the relationship between
stone formation and BC remains unclear [16,17]. There-
fore, using a population-based dataset in Taiwan, this
study set out to explore the association of BC with a
previous diagnosis of bladder calculus.Methods
Database
We obtained the data for the analyses performed in this
study from the Longitudinal Health Insurance Database
2000 (LHID2000), which is derived from the Taiwan Na-
tional Health Insurance (NHI) program. The LHID2000
comprises all the registration files and medical claims
for the reimbursement of 1,000,000 beneficiaries, and is
provided to scientists in Taiwan for research purposes.
The selected beneficiaries of the LHID2000 were ran-
domly retrieved from the year 2000 Registry of Benefi-
ciaries (n = 23.72 million) of the NHI program. The
Taiwan National Health Research Institute has demon-
strated that the sex distribution of the LHID2000 is rep-
resentative of the whole population of NHI enrollees.
Numerous researchers have used this dataset to perform
and publish studies in internationally peer-reviewed
journals.
As the LHID2000 consists of de-identified secondary
data released to the public for research purposes, this
study was exempted from full review after consulting
with the director of the Institutional Review Board (IRB)
of Taipei Medical University.Selection of cases and controls
We selected cases by identifying those patients (n =
2,086) ≥ 40 years old who had received their first-time
diagnosis of BC (ICD-9-CM codes 188 or 188.0-188.9)
in ambulatory care visits or hospitalizations between
January 1, 2001 and December 31, 2009. We assigned
the date of their first-time diagnosis of BC as their index
date.
For controls, we selected five subjects for each case
from the remaining beneficiaries in the LHID2000. In
total, 10,430 subjects were frequency-matched with cases
by sex, 10-year age groups (40–49, 50–59, 60–69, 70–
79, and >79), urbanization level of the patient’s residence
(5 levels, with 1 referring to the “most urbanized”, and 5
the “least urbanized”), and index year and selected as
controls. Controls were matched with cases in terms of
urbanization level to help assure that cases and controls
were reasonably similar in regard to unmeasured neigh-
borhood socioeconomic characteristics.Exposure assessment
We identified cases with bladder calculus by ICD-9-CM
codes 594.0 (calculus in diverticulum of bladder) or
594.1 (other calculus in bladder) prior to index date. In
order to ensure for high diagnostic validity, we only se-
lected cases who had more than one bladder calculus
diagnostic claim, with at least one diagnosis being made
by a urologist or nephrologist.
Statistical analysis
The SAS statistical package (SAS System for Windows,
Version 8.2, Cary, NC) was used to perform all the stat-
istical analyses conducted in this study. We utilized
Pearson χ2 tests to examine the distribution of
sociodemographic characteristics (monthly income and
geographic region (Northern, Central, Eastern, and
Southern Taiwan)) and the prevalence of co-morbidities.
The prevalence of comorbidities, including hypertension
(ICD-9-CM codes 401 ~ 405), diabetes (ICD-9-CM code
250), coronary heart disease (CHD) (ICD-9-CM codes
410 ~ 414), renal disease (ICD-9-CM codes 582 ~ 586),
tobacco use disorder (ICD-9-CM code 305.1), obesity
(ICD-9-CM code 278), alcohol abuse (ICD-9-CM codes
303), schistosomiasis (ICD-9-CM code 120), bladder
outlet obstruction (ICD-9-CM code 596.0), and urinary
tract infections (ICD-9-CM codes 599.0, 595.0, or 595.9)
within 3 years prior to the index date were included
[8,11,16]. Conditional logistic regressions (conditioned
on sex, age group, urbanization level, and index year)
were employed to explore the association between BC
and having been previously diagnosed with bladder cal-
culus. We further computed the odds ratio (OR) for ha-
ving been previously diagnosed with bladder calculus
stratified by sex. The conventional p ≤ 0.05 was used to
assess statistical significance.
Results
The mean age for the 12,516 sampled patients was 64.4 -
years with a standard deviation of 16 years. Table 1
shows the distribution of sociodemographic characteris-
tics and co-morbidities between cases and controls.
After matching for sex, age group, urbanization level,
and index year, there was no significant difference in
monthly income, geographic region, CHD, and diabetes
between cases and controls. However, cases were more
likely to have renal disease (p < 0.001), urinary tract in-
fection (p < 0.001), tobacco use disorder (p < 0.001), but
less likely to have hypertension (p = 0.018), than con-
trols. No sampled subjects had ever received a diagnosis
of schistosomiasis since the initiation of the NHI
program.
Table 2 shows the prevalence of prior bladder calculus
between cases and controls. Of 12,516 sampled subjects,
176 (1.4%) had bladder calculus prior to the index date;
Table 1 Demographic characteristics of patients with bladder cancer and comparison group patients in Taiwan,
2001–2009 (n = 12,516)
Variable Patients with bladder cancer Comparison patients P value
n = 2,086 n = 10,430
Total No. Column % Total No. Column %
Age 1.000
40-49 287 13.8 1,435 13.8
50-59 377 18.1 1,885 18.1
60-69 482 23.1 2,410 23.1
70-79 604 28.9 3,020 28.9
>79 336 16.1 1,680 16.1
Sex 1.000
Male 1,332 63.9 6,660 63.9
Female 754 36.1 3,770 36.1
Urbanization level 1.000
1 (most urbanized) 707 33.9 3,535 33.9
2 568 27.2 2,840 27.2
3 276 13.2 1,380 13.2
4 290 13.9 1,450 13.9
5 (least urbanized) 245 11.7 1,225 11.7
Monthly income 0.963
NT$0-15,840 770 36.9 3,817 36.6
NT$15,841-25,000 903 43.3 4,537 43.5
≥NT$25,001 413 19.8 2,076 19.9
Geographical Region 0.911
Northern 1,017 48.7 5,006 48.0
Central 438 21.0 2,222 21.3
Southern 581 27.9 2,962 28.4
Eastern 50 2.4 240 2.3
Hypertension 972 46.6 5,155 49.4 0.018
Renal disease 332 15.9 73 7.0 <0.001
Coronary heart disease 455 21.8 2,445 23.4 0.107
Diabetes 452 21.7 2,190 21.0 0.493
Schistosomiasis 0 – 0 – –
Bladder outlet obstruction 35 1.7 146 1.4 0.307
Urinary tract infection 724 34.7 2,931 28.1 <0.001
Tobacco use disorder 110 5.3 350 3.4 <0.001
Alcohol abuse 20 1.0 100 1.0 0.998
Obesity 30 1.4 98 1.0 0.145
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(1.1%) controls (chi-square value = 72.036; p < 0.001).
Conditional logistic regression analysis (conditioned on age
group, sex, urbanization level, and index year) revealed that
the OR of having been diagnosed with bladder calculus be-
fore the index date for cases was 3.47 (95% CI = 2.55-4.70;
p < 0.001) when compared with controls. After adjusting
for monthly income, geographic region, hypertension,diabetes, CHD, and renal disease, tobacco use disorder,
obesity, alcohol abuse, and schistosomiasis, bladder outlet
obstruction, and urinary tract infection, cases were more
likely to have a prior diagnosis of bladder calculus than
controls (OR = 3.42; 95% CI = 2.48-4.72; p < 0.001).
We further analyzed the OR of having been previously
diagnosed with bladder calculus according to sex
(Table 3). After adjusting for patient monthly income,
Table 2 Covariate-adjusted hazard ratios for bladder
calculus among the sampled patients
Variable Bladder cancer
Odds ratio 95% CI P value
Prior bladder calculus
Yes 3.42 2.48-4.72 <0.001
No (reference group) 1.00
Monthly Income
NT$1-15,840 (reference group) 1.00
NT$15,841-25,000 0.98 0.97-1.01 0.317
≥NT$25,001 1.01 0.98-1.02 0.891
Geographic region
Northern (reference group) 1.00
Central 0.92 0.80-1.07 0.279
Eastern 0.98 0.86-1.11 0.692
Southern 0.94 0.68-1.31 0.722
Hypertension 0.80 0.72-0.89 0.008
Renal disease 2.65 2.28-3.08 <0.001
Coronary heart disease 0.87 0.73-1.05 0.060
Diabetes 0.98 0.86-1.11 0.742
Bladder outlet obstruction 0.90 0.46-1.76 0.751
Urinary tract infection 1.23 1.07-1.38 <0.001
Tobacco use disorder 1.46 1.26-1.68 <0.001
Alcohol abuse 0.99 0.88-1.44 0.983
Obesity 1.03 0.98-1.06 0.056
Notes: CI = confidence interval; OR was calculated using Cox proportional
hazard regression, stratified by sex, age, and urbanization level group.
Table 3 Covariate-adjusted hazard ratios for bladder









Yes 3.45*** (2.39-4.99) 3.05** (1.53-6.08)
No (reference group) 1.00 1.00
Monthly Income
NT$1-15,840 (reference group) 1.00 1.00
NT$15,841-25,000 1.21* (1.05-1.40) 1.24* (1.03-1.49)
≥NT$25,001 1.33** (1.13-1.57) 1.47** (1.12-1.92)
Geographic region
Northern (reference group) 1.00 1.00
Central 0.98 (0.83-1.17) 0.83 (0.65-1.07)
Eastern 1.06 (0.90-1.23) 0.86 (0.70-1.07)
Southern 1.09 (0.73-1.62) 0.74 (0.42-1.32)
Hypertension 0.88 (0.77-1.01) 0.69*** (0.57-0.82)
Renal disease 1.94*** (1.60-2.37) 4.37*** (3.44-5.55)
Coronary heart disease 0.73** (0.63-0.86) 1.03 (0.83-1.28)
Diabetes 0.95 (0.81-1.12) 1.04 (0.85-1.28)
Bladder outlet obstruction 0.90 (0.45-1.79) 0.45 (0.02-13.73)
Urinary tract infection 1.08*** (1.04-1.11) 1.53 (1.47-1.58))
Tobacco use disorder 1.29*** (1.13-1.48) 1.68*** (1.62-1.74)
Alcohol abuse 0.95 (0.83-1.09) 0.99 (0.95-1.03)
Obesity 1.03 (0.99-1.06) 1.07 (0.99-1.12)
Notes: OR was calculated using Cox proportional hazard regression, stratified
by age and urbanization level group.
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renal disease, tobacco use disorder, obesity, alcohol
abuse, and schistosomiasis, bladder outlet obstruction,
and urinary tract infection, conditional logistic regres-
sion analysis revealed that among males, the OR of ha-
ving been previously diagnosed with bladder calculus for
cases was 3.45 (95% CI = 2.39-4.99; p < 0.001) that of
controls. Among females, the OR of having been pre-
viously diagnosed with bladder calculus for cases was
3.05 (95% CI = 1.53-6.08; p = 0.002) that of controls.Discussion
This study succeeded in identifying an association be-
tween BC and a prior diagnosis of bladder calculus. We
found bladder cancer patients to be 3.42 times more
likely than controls to have had a previous diagnosis of
bladder calculus. We also found the magnitude of asso-
ciation to be significantly stronger among men than
among women. Men with BC were 3.45 times more
likely than controls to have had a previous diagnosis of
bladder calculus, while women were only 3.05 times
more likely.Several previous studies have been conducted on this
association, but their results are in conflict. The largest
case–control study performed to date set out to evaluate
the role of urinary tract infection (UTI) and inflamma-
tion in the etiology of BC and was conducted on 2,982
bladder carcinoma patients and 5,782 population con-
trols from ten geographic areas of the United States.
They found a history of UTI to significantly increase the
risk of BC. This was stronger in individuals with three
or more reported infections (RR = 2.0). But, irrespective
of UTI, they also found a significantly increased risk of
BC among patients with bladder stones (RR = 1.8) [18].
There were two other studies conducted on the asso-
ciation between bladder calculus and BC, but they failed
to detect an association [17,19]. The first of these inves-
tigations was a population-based study conducted in
Greater Copenhagen between 1979 and 1981. This study
included 388 patients with BC and 790 controls [18].
The second study investigated the relationship between
selected urinary tract and genital diseases and the risk of
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of 364 cases of BC and 447 controls hospitalized for
acute, nonneoplastic, nongenital tract conditions, unre-
lated to known or suspected risk factors for BC.
As opposed to these studies which failed to detect an
association between bladder calculus and BC, the results
of this investigation support the presence of an asso-
ciation and are in-line with the one previous large-scale
study [18]. The mechanisms underlying the associations
detected in this study may involve the chronic irritation
and inflammation associated with bladder calculus. One
source of this inflammation is from the direct irritation
of the bladder epithelial wall and another may stem from
urinary tract infections which are strongly associated
with urinary stones [8,20].
There is substantial evidence that inflammation can
play a direct role in carcinogenesis [21,22]. Both infec-
tion and irritation can cause tissue injury and result in
the activation of both inflammatory cells and oxidant-
generating enzymes [22]. Chronic inflammation can in-
duce tissue and deoxyribonucleic acid (DNA) damage by
generating reactive oxygen and nitrogen species [21,23].
The presence of stones and infections has been dem-
onstrated to be important factors in the development of
bladder tumors in rodents. Furthermore, these tumors are
generally TCC [9], thus adding further evidence for a
mechanistic connection between BC and bladder calculus
in the absence of members of the genus Schistosoma.
This study’s strengths include the use of a population-
based dataset, which enabled us to trace of all the cases
of BC and bladder calculus during the study period. The
large sample size afforded a considerable statistical ad-
vantage in detecting real differences between the two co-
horts. Nevertheless, the results of this study need to be
seen in the light of several limitations. The first limitation
is that the diagnoses of both BC and bladder calculus relied
on administrative claims data reported by physicians and
hospitals. These data may be less accurate than diagnoses
made according to standardized criteria.
Second, some patient information on factors which
may have had an effect on the associations detected in
this study was not available through the administrative
dataset. Some of those factors include tobacco use, alco-
hol and betel quid consumption, dietary habits, and the
body mass index. However, although we adjusted for to-
bacco use disorder in the regression model, this could
merely mean that those subjects with such a diagnosis
have undergone smoking cessation therapy. We might
underestimate to use the variable as tobacco smoke be-
cause the people who receive smoking cessation therapy
in clinic are only a small proportion of the smoker. One
other important factor that we lacked was any exposure
to aromatic amines which have been proven to contrib-
ute to the development of BC [11].Third, this study may have been partially victim to a
surveillance bias since patients with bladder calculus are
more likely to have frequent outpatient clinic visits. But,
as the first indication of BC is generally blood in the
urine, it is unlikely that surveillance bias impacted the
results of this study.
Conclusion
This investigation detected an association between BC
and prior bladder calculus after adjusting for co-morbid
medical disorders and social economic factors. These re-
sults add to the evidence surrounding the conflicting re-
ports regarding the association between BC and prior
bladder calculus and highlight a potential target popula-
tion for bladder cancer screening.
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